![](https://endpts.com/wp-content/uploads/2020/01/epn-peer-review@x2.jpg)
Bridget Martell on taking Yale spinout 'to adulthood'; Cullinan Oncology CEO announces resignation as Bristol Myers hematology exec is welcomed aboard
Bridget Martell’s first clinical trial was an unorthodox one.
Then a resident in internal medicine at Yale, she was given an award to explore a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.